- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股处于空头行情中，可能有短期反弹。
- 中期趋势：
-
- 长期趋势：
已有64家主力机构披露2024-12-31报告期持股数据，持仓量总计1.20亿股，占流通A股44.17%
- 波段诊断：
-
技术面诊股
诊断结果：2.4技术面打败了28%的股票
技术面评分前10的股票
近期的平均成本为14.80元。
平均成本
近期的平均成本为14.80元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"14.80","date":1743582155,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2025.04.03","stock":"-1.81","trade":null,"ind":"-1.40"},{"date":"2025.04.02","stock":"-2.29","trade":null,"ind":"0.09"},{"date":"2025.04.01","stock":"4.73","trade":null,"ind":"-0.01"},{"date":"2025.03.31","stock":"-7.42","trade":null,"ind":"-0.97"},{"date":"2025.03.28","stock":"0.45","trade":null,"ind":"-0.57"},{"date":"2025.03.27","stock":"0.96","trade":null,"ind":"0.23"},{"date":"2025.03.26","stock":"0.32","trade":null,"ind":"-0.05"},{"date":"2025.03.25","stock":"0.52","trade":null,"ind":"-0.43"},{"date":"2025.03.24","stock":"-1.47","trade":null,"ind":"0.07"},{"date":"2025.03.21","stock":"-2.49","trade":null,"ind":"-1.76"},{"date":"2025.03.20","stock":"-1.17","trade":null,"ind":"-0.91"},{"date":"2025.03.19","stock":"-0.37","trade":null,"ind":"-0.32"},{"date":"2025.03.18","stock":"0.25","trade":null,"ind":"0.52"},{"date":"2025.03.17","stock":"1.25","trade":null,"ind":"-0.19"},{"date":"2025.03.14","stock":"2.42","trade":null,"ind":"2.26"},{"date":"2025.03.13","stock":"-0.70","trade":null,"ind":"-0.99"},{"date":"2025.03.12","stock":"-0.75","trade":null,"ind":"-0.17"},{"date":"2025.03.11","stock":"-0.31","trade":null,"ind":"0.33"},{"date":"2025.03.10","stock":"0.82","trade":null,"ind":"-0.17"},{"date":"2025.03.07","stock":"-1.55","trade":null,"ind":"-0.50"},{"date":"2025.03.06","stock":"2.94","trade":null,"ind":"1.77"}]
迪瑞医疗,深证成指,医疗器械指数
压力支撑
该股压力位为14.84元，支撑位为14.57元。
[{"text":"\u538b\u529b\u4f4d","value":"14.84","date":1743609600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.57","date":1743609600,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.3资金面打败了33%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体无进出。
更新时间：04月03日 20:34
| 机构今日流向(万元) | -756.14 | 机构5日流向(万元) | -152.31 |
| 机构10日流向(万元) | -2146.15 | 机构20日流向(万元) | -8110.62 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少3885.07万股，其中基金净减仓9家，主力净减仓146家，请投资者中长期谨慎为宜。
截止2024-12-31，共64家主力机构（基金60家，一般法人4家），持仓量总计12035.34万股，占流通A股44.17%
其中，基金持仓与2024-06-30相比：
增仓：15家 ，增持 143.21万股
减仓：24家 ，减持 568.49万股
新出现在主力名单中：18家 ，持有300.38万股
从主力名单中消失：164家 ，原持有3760.17万股
其中，基金持仓与2024-06-30相比：
增仓：15家 ，增持 143.21万股
减仓：24家 ，减持 568.49万股
新出现在主力名单中：18家 ，持有300.38万股
从主力名单中消失：164家 ，原持有3760.17万股
消息面诊股
诊断结果：6.1消息面打败了81%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 迪瑞医疗：多模态+AI大模型算法技术助力提升诊疗效
2025-04-02 - 概念动态|迪瑞医疗新增“多模态AI”概念
2025-04-02 - 迪瑞医疗：公司已经建立系列的应收账款处置机制，应收
2025-04-01 - 迪瑞医疗：公司调整销售节奏重点强化多个品种的注册
2025-04-01 - 迪瑞医疗：存货跌价或减值与库存商品期末价值没有直接
2025-04-01 - 迪瑞医疗：年末我们对原材料进行了判断评估需要计提的
2025-04-01 - 迪瑞医疗：通过提高试剂占比降本增效来提升整体盈利能
2025-03-31 - 迪瑞医疗：公司调整了销售政策对国内市场营业收入造成
2025-03-31 - 信澳中小盘混合重仓股迪瑞医疗跌7.42%
2025-03-31 - 股东追踪|博时医疗保健混合A等新进迪瑞医疗前十大流
2025-03-29
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2025-03-29 |
| 利好 | 分红转增 | 10派2.6元(含税) | 2025-03-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-29 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-03-27 |
| 一般消息 | 高管变动 | 工作安排原因 | 2024-10-24 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-23 |
| 一般消息 | 高管变动 | 因个人原因 | 2024-07-02 |
| 一般消息 | 高管变动 | 因于个人原因 | 2024-05-10 |
| 一般消息 | 重大事项 | 关联交易 | 2024-05-10 |
| 利好 | 分红转增 | 10派5元(含税) | 2024-04-19 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-04-18 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了1%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2025.04.03","price":"-1.40","value":null},{"date":"2025.04.02","price":"0.09","value":null},{"date":"2025.04.01","price":"-0.01","value":null},{"date":"2025.03.31","price":"-0.97","value":null},{"date":"2025.03.28","price":"-0.57","value":null},{"date":"2025.03.27","price":"0.23","value":null},{"date":"2025.03.26","price":"-0.05","value":null},{"date":"2025.03.25","price":"-0.43","value":null},{"date":"2025.03.24","price":"0.07","value":null},{"date":"2025.03.21","price":"-1.76","value":null},{"date":"2025.03.20","price":"-0.91","value":null},{"date":"2025.03.19","price":"-0.32","value":null},{"date":"2025.03.18","price":"0.52","value":null},{"date":"2025.03.17","price":"-0.19","value":null},{"date":"2025.03.14","price":"2.26","value":null},{"date":"2025.03.13","price":"-0.99","value":null},{"date":"2025.03.12","price":"-0.17","value":null},{"date":"2025.03.11","price":"0.33","value":null},{"date":"2025.03.10","price":"-0.17","value":null},{"date":"2025.03.07","price":"-0.50","value":null},{"date":"2025.03.06","price":"1.77","value":"-357279036.44"}]
深证成指,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 乐心医疗 | 150.70% | 2.42% | 4.5分 |
| 2 | 热景生物 | 25.15% | 16.67% | 4.6分 |
| 3 | 怡和嘉业 | 23.58% | 3.45% | 5.3分 |
| 4 | 伟思医疗 | 22.71% | 31.92% | 4.8分 |
| 5 | 惠泰医疗 | 12.48% | 5.57% | 5.8分 |
| 6 | 力诺药包 | 10.72% | 1.17% | 5.0分 |
| 8 | 华兰股份 | 9.62% | -3.99% | 3.5分 |
| 10 | 麦澜德 | 9.26% | 0.95% | 3.6分 |
| 12 | 海利生物 | 8.99% | 9.45% | 4.4分 |
| 14 | 山外山 | 8.74% | -3.42% | 4.1分 |
| 16 | 三鑫医疗 | 7.76% | 2.12% | 4.7分 |
| 18 | 澳华内镜 | 7.55% | 1.87% | 4.9分 |
| 20 | 迈普医学 | 6.70% | 2.14% | 5.0分 |
| 22 | 大博医疗 | 5.42% | 6.02% | 5.6分 |
| 24 | 心脉医疗 | 4.61% | 4.18% | 5.4分 |
| 26 | 美康生物 | 4.41% | 5.71% | 4.4分 |
| 28 | 正海生物 | 4.05% | 1.67% | 4.1分 |
| 30 | 正川股份 | 3.59% | -0.50% | 4.6分 |
| 32 | 洁特生物 | 3.11% | 3.39% | 4.8分 |
| 34 | 健帆生物 | 2.69% | -1.01% | 5.2分 |
| 36 | 博拓生物 | 2.32% | -1.84% | 4.2分 |
| 38 | 开立医疗 | 2.02% | 1.13% | 4.2分 |
| 40 | 安图生物 | 1.26% | -0.30% | 5.2分 |
| 42 | 赛诺医疗 | 1.22% | -0.37% | 4.8分 |
| 44 | 山东药玻 | 1.03% | -1.92% | 4.8分 |
| 46 | 尚荣医疗 | 0.58% | 3.60% | 4.6分 |
| 48 | 爱迪特 | 0.38% | -0.37% | 3.9分 |
| 50 | 基蛋生物 | 0.23% | -0.80% | 4.6分 |
| 52 | 微电生理 | -0.05% | 4.16% | 4.9分 |
| 54 | 迈克生物 | -0.22% | -1.03% | 3.7分 |
| 56 | 赛科希德 | -0.58% | 2.43% | 4.7分 |
| 58 | 万孚生物 | -0.71% | 0.59% | 4.0分 |
| 60 | 昊海生科 | -1.02% | -0.32% | 5.0分 |
| 62 | 天臣医疗 | -1.31% | 3.53% | 5.1分 |
| 64 | 利德曼 | -1.60% | 0.00% | 4.4分 |
| 66 | 东星医疗 | -2.02% | 2.62% | 4.7分 |
| 68 | 仁度生物 | -2.16% | 2.15% | 4.4分 |
| 70 | 安旭生物 | -2.57% | -0.64% | 4.2分 |
| 72 | 拱东医疗 | -2.77% | -1.58% | 5.1分 |
| 74 | 福瑞股份 | -2.98% | -1.50% | 4.4分 |
| 76 | 英科医疗 | -3.13% | -2.26% | 3.9分 |
| 78 | 鱼跃医疗 | -3.60% | -0.06% | 5.0分 |
| 80 | 美好医疗 | -3.66% | -3.66% | 4.4分 |
| 82 | 宝莱特 | -3.77% | 0.42% | 3.7分 |
| 84 | 东富龙 | -3.89% | 0.15% | 3.7分 |
| 86 | 南卫股份 | -4.34% | 1.54% | 4.0分 |
| 88 | 超研股份 | -4.64% | 6.60% | 5.2分 |
| 90 | 翔宇医疗 | -4.87% | 7.81% | 3.7分 |
| 92 | 安杰思 | -5.05% | 1.38% | 4.9分 |
| 94 | 爱威科技 | -5.63% | 0.65% | 4.2分 |
| 96 | 科美诊断 | -5.80% | -1.42% | 4.1分 |
| 98 | 睿昂基因 | -5.95% | 2.18% | 3.6分 |
| 100 | 理邦仪器 | -6.06% | -0.33% | 3.9分 |
| 102 | 奥精医疗 | -6.47% | -1.60% | 3.2分 |
| 104 | 联影医疗 | -7.86% | 0.97% | 4.7分 |
| 106 | 济民健康 | -8.02% | 4.64% | 3.9分 |
| 108 | 迈瑞医疗 | -8.92% | -7.06% | 5.1分 |
| 110 | 佰仁医疗 | -9.77% | -0.50% | 4.0分 |
| 112 | 海泰新光 | -10.89% | -8.38% | 3.9分 |
| 114 | 圣湘生物 | -11.93% | -0.68% | 3.7分 |
| 116 | 济高发展 | -13.14% | -2.52% | 3.7分 |
| 118 | 祥生医疗 | -14.30% | -0.22% | 3.8分 |
| 120 | 麦克奥迪 | -17.28% | -6.00% | 3.9分 |
| 122 | 康为世纪 | -17.88% | -2.55% | 2.9分 |
| 124 | - | -57.89% | -14.16% | 分 |
| 126 | 黄山胶囊 | - | 1.18% | 3.7分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 21/250 ， 85/250。
[{"date":"2024-09-30","value":"9.31","vol":"4.78"},{"date":"2024-06-30","value":"8.04","vol":"3.54"},{"date":"2024-03-31","value":"5.80","vol":"1.67"},{"date":"2023-12-31","value":"13.92","vol":"12.40"},{"date":"2023-09-30","value":"11.83","vol":"5.64"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
9.31 | 8.04 | 5.80 | 13.92 | 11.83 |
| 行业(%) | 4.78 | 3.54 | 1.67 | 12.40 | 5.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"43.41","vol":"53.43"},{"date":"2024-06-30","value":"43.10","vol":"53.63"},{"date":"2024-03-31","value":"36.40","vol":"53.16"},{"date":"2023-12-31","value":"50.53","vol":"53.54"},{"date":"2023-09-30","value":"49.85","vol":"53.90"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
43.41 | 43.10 | 36.40 | 50.53 | 49.85 |
| 行业(%) | 53.43 | 53.63 | 53.16 | 53.54 | 53.90 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 34/250 ， 74/250。
[{"date":"2024-09-30","value":"12.10","vol":"1.29"},{"date":"2024-06-30","value":"26.38","vol":"0.73"},{"date":"2024-03-31","value":"99.60","vol":"-0.80"},{"date":"2023-12-31","value":"12.96","vol":"-6.88"},{"date":"2023-09-30","value":"30.69","vol":"-6.02"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
12.10 | 26.38 | 99.60 | 12.96 | 30.69 |
| 行业(%) | 1.29 | 0.73 | -0.80 | -6.88 | -6.02 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"-17.80","vol":"-19.70"},{"date":"2024-06-30","value":"2.12","vol":"9.59"},{"date":"2024-03-31","value":"56.73","vol":"-15.89"},{"date":"2023-12-31","value":"5.26","vol":"-23.68"},{"date":"2023-09-30","value":"20.35","vol":"0.42"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-17.80 | 2.12 | 56.73 | 5.26 | 20.35 |
| 行业(%) | -19.70 | 9.59 | -15.89 | -23.68 | 0.42 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 25/250 ， 72/250。
[{"date":"2024-09-30","value":"0.37","vol":"0.26"},{"date":"2024-06-30","value":"0.28","vol":"0.18"},{"date":"2024-03-31","value":"0.20","vol":"0.09"},{"date":"2023-12-31","value":"0.44","vol":"0.37"},{"date":"2023-09-30","value":"0.35","vol":"0.27"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.37 | 0.28 | 0.20 | 0.44 | 0.35 |
| 行业(次) | 0.26 | 0.18 | 0.09 | 0.37 | 0.27 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.25","vol":"1.68"},{"date":"2024-06-30","value":"0.91","vol":"1.13"},{"date":"2024-03-31","value":"0.83","vol":"0.55"},{"date":"2023-12-31","value":"1.44","vol":"2.28"},{"date":"2023-09-30","value":"1.18","vol":"1.59"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.25 | 0.91 | 0.83 | 1.44 | 1.18 |
| 行业(次) | 1.68 | 1.13 | 0.55 | 2.28 | 1.59 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"-3.92","vol":"15.40"},{"date":"2024-06-30","value":"-48.05","vol":"12.72"},{"date":"2024-03-31","value":"-27.78","vol":"2.14"},{"date":"2023-12-31","value":"51.23","vol":"39.09"},{"date":"2023-09-30","value":"-2.87","vol":"18.01"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -3.92 | -48.05 | -27.78 | 51.23 | -2.87 |
| 行业 | 15.40 | 12.72 | 2.14 | 39.09 | 18.01 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.01"},{"date":"2024-06-30","value":"0.50","vol":"2.32"},{"date":"2024-03-31","value":"","vol":"0.06"},{"date":"2023-12-31","value":"0.73","vol":"2.85"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.50 | - | 0.73 | - |
| 行业 | 0.01 | 2.32 | 0.06 | 2.85 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/250 ， 12/250。
[{"date":"2024-09-30","value":"1.92","vol":"5.98"},{"date":"2024-06-30","value":"1.89","vol":"5.99"},{"date":"2024-03-31","value":"1.88","vol":"6.56"},{"date":"2023-12-31","value":"1.66","vol":"5.82"},{"date":"2023-09-30","value":"2.01","vol":"6.72"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.92 | 1.89 | 1.88 | 1.66 | 2.01 |
| 行业 | 5.98 | 5.99 | 6.56 | 5.82 | 6.72 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.17","vol":"4.82"},{"date":"2024-06-30","value":"1.12","vol":"4.93"},{"date":"2024-03-31","value":"1.29","vol":"5.47"},{"date":"2023-12-31","value":"1.04","vol":"4.82"},{"date":"2023-09-30","value":"1.27","vol":"5.64"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.17 | 1.12 | 1.29 | 1.04 | 1.27 |
| 行业 | 4.82 | 4.93 | 5.47 | 4.82 | 5.64 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 22/250 ， 26/250。
[{"date":"2024-09-30","value":"31.73","vol":"21.14"},{"date":"2024-06-30","value":"32.03","vol":"21.13"},{"date":"2024-03-31","value":"33.57","vol":"20.72"},{"date":"2023-12-31","value":"38.59","vol":"21.25"},{"date":"2023-09-30","value":"33.48","vol":"21.16"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
31.73 | 32.03 | 33.57 | 38.59 | 33.48 |
| 行业(%) | 21.14 | 21.13 | 20.72 | 21.25 | 21.16 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.46","vol":"0.38"},{"date":"2024-06-30","value":"0.47","vol":"0.37"},{"date":"2024-03-31","value":"0.51","vol":"0.37"},{"date":"2023-12-31","value":"0.63","vol":"0.37"},{"date":"2023-09-30","value":"0.50","vol":"0.35"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.46 | 0.47 | 0.51 | 0.63 | 0.50 |
| 行业(%) | 0.38 | 0.37 | 0.37 | 0.37 | 0.35 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"2.10","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"2.62","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.76","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.42","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"3.82","blueLineValue":"1.40","type":"YC"}]